Fig. 3

Calculated AV values of IPR and FEN for group 1 (inhaler 1; B.N. 104604) and group 2 (inhaler 2; B.N. 204632) in Atrovent® comp HFA oral inhaler. Each group of 10 units was individually assayed. The dashed line indicates the requirements of the USP Pharmacopoeia (AV ≤ 15%).